2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Ponikowski, Piotr; Voors, Adriaan A.; Anker, Stefan D.; Bueno, Héctor; Cleland, John G.F.; Coats, Andrew J.S.; Falk, Volkmar; González-Juanatey, José Ramón; Harjola, Veli‐Pekka; Jankowska, Ewa A.; Jessup, Mariell; Linde, Cecilia; Nihoyannopoulos, Petros; Parissis, John; Pieske, Burkert; Riley, Jillian; Rosano, Giuseppe; Ruilope, Luís M.; Ruschitzka, Frank; Rutten, Frans H.; Meer, Peter van der

doi:10.5603/kp.2016.0141

Cited by 459 publications

(601 citation statements)

References 383 publications

(552 reference statements)

Supporting

Mentioning

521

Contrasting

Unclassified

Order By: Relevance

“…The right ventricular pacing can be life-saving but in the long term it can also contribute to the so-called pacing cardiomyopathy in a substantial part of paced patients [8]. The bi-ventricular pacing, better known as cardiac resynchronization therapy, was introduced to correct the left bundle branch block--related dyssynchrony and could of course be considered in the presented patient according to the Guidelines [2]. There are, however, two important drawbacks of this approach.…”

Section: Discussionmentioning

confidence: 99%

“…However, the high heart rate results in some forms of tachycardiomyopathy which was obviously present in our patient. Even if the structural changes are not so prominent the excessive increase in a heart rate on exertion contributes to the left ventricle www.journals.viamedica.pl/folia_cardiologica Agnieszka Sławuta et al, Upgrade of pacing system in permanent atrial fibrillation A B heart failure symptoms in many atrial fibrillation patients, and is known as a heart failure with preserved ejection fraction [2]. We aim at indicating a paradox in patients with an implanted device, being only able to pace the right ventricle: the increase of the beta-adrenolytic dose can of course prevent the heart rate increase but at the same time this increases the percentage of the deleterious right ventricular pacing.…”

Section: Discussionmentioning

confidence: 99%

“…This approach can be of certain use probably in the majority of patients with a normal heart, however, in some cases, in particular with the preexisting structural heart disease, the episodes of tachyarrhythmia resulting from an inadequate beta-blockade, and/or a higher percentage of right ventricular pacing can deleteriously influence the left ventricle performance, leading to cardiac remodeling, and ultimately to heart failure. The atrial fibrillation, and the right ventricular pacing have both a well-known negative influence on the left ventricle mechanical performance [2]. Both circumstances decrease the cardiac output contributing, by different mechanisms, to the development of cardiomyopathy whose signs and symptoms could be more pronounced in a previously existing damage or in genetically susceptible individuals [3].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Optymalna rozbudowa dwujamowego układu stymulującego u pacjentki z utrwalonym migotaniem przedsionków

et al. 2017

View full text Add to dashboard Cite

In patients with sick sinus syndrome, and previously implanted dual-chamber pacemaker, the occurrence of atrial fibrillation finally assessed as permanent is most commonly regarded as a natural course of the disease. The inappropriate heart rate control and right ventricular pacing can both negatively influence left ventricle mechanical performance leading to cardiomyopathy and heart failure.It was presented the case of a 72-year-old woman with permanent atrial fibrillation with narrow QRS complex, after dual-chamber pacemaker implantation, admitted to our department with signs and symptoms of acute decompensated congestive heart failure. The modification of pharmacotherapy allowed to compensate heart failure, however with only small influence on structural remodelling and patient's symptoms. The successful upgrade of the pacing system to the direct His-bundle pacing enabled the restoration of proper function of the heart and full symptoms relief. The direct His-bundle pacing is an approach of choice in such a group of patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Optymalna rozbudowa dwujamowego układu stymulującego u pacjentki z utrwalonym migotaniem przedsionków

et al. 2017

View full text Add to dashboard Cite

show abstract

“…It is estimated that the prevalence of HF is 1-2% in the general population and as high as 10% in patients over 70 years of age [1]. Rapid increase in the number of patients with HF is a consequence of both the aging of society and the development of interventional cardiology and electrotherapy.…”

Section: Introductionmentioning

confidence: 99%

Clinical characteristic of 100 patients from pilot registry of heart failure patients hospitalized in the district hospital in Poland

Praska-Oginska¹,

Bednarski²

2017

Folia Cardiologica

View full text Add to dashboard Cite

“…The prevalence of HF is approximately 1–2% in the adult population in developed countries, rising to ≥10% among people ≥70 years of age [1]. The rapidly rising prevalence of HF mandates a more comprehensive understanding of the natural history of the disease in order to identify its prognostic factors.…”

Section: Introductionmentioning

confidence: 99%

Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure

Liu

Zheng²,

Dong

et al. 2018

Cardiology

View full text Add to dashboard Cite

Objective: The aim of this study was to identify heart failure (HF)-specific circulating micro-RNAs (miRNA), and examine whether the selected miRNAs correlate with myocardial fibrosis and are reflective of the incidence of adverse cardiovascular events in patients with stage C or D HF. Methods: Circulating miRNAs which were expressed in end-stage HF patients and matched healthy controls were detected by microarray analysis and validated by quantitative real-time polymerase chain reaction. Multivariate Cox regression analysis was performed to determine whether the selected circulating miRNAs could be prognostic factors in HF patients. Results: In a cohort of 7 healthy controls and 9 patients with stage C or D HF, 7 miRNAs were differentially expressed. These miRNAs were further investigated in a second cohort of 80 patients with stage C or D HF and 30 healthy controls. Only miR-197-5P correlated with fibrosis as seen in cardiac magnetic resonance imaging in patients under the age of 50 years with stage C or D HF (r = 0.42, p = 0.008). Multivariate analyses revealed that miR-197-5P was also a risk factor for composite endpoint events in patients under the age of 50 years with stage C or D HF. Conclusion: miR-197-5P is a circulation miRNA that correlates with MF and adverse cardiac events in HF patients under the age of 50 years.

show abstract

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Cited by 459 publications

References 383 publications

Optymalna rozbudowa dwujamowego układu stymulującego u pacjentki z utrwalonym migotaniem przedsionków

Optymalna rozbudowa dwujamowego układu stymulującego u pacjentki z utrwalonym migotaniem przedsionków

Clinical characteristic of 100 patients from pilot registry of heart failure patients hospitalized in the district hospital in Poland

Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure

Contact Info

Product

Resources

About